Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Cerilliant
Farmers Insurance
Chinese Patent Office
Healthtrust
Boehringer Ingelheim
AstraZeneca
Accenture

Generated: November 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DOPAMINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Dopamine Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00000276 Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 Terminated National Institute on Drug Abuse (NIDA) Phase 1 The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.
NCT00000276 Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 Terminated VA Connecticut Healthcare System Phase 1 The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.
NCT00000276 Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 Terminated Yale University Phase 1 The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.
NCT00000309 Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1 Terminated National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.
NCT00000309 Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1 Terminated VA Boston Healthcare System Phase 2 The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.
NCT00000309 Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1 Terminated Butler Hospital Phase 2 The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Dopamine Hydrochloride

Condition Name

Condition Name for Dopamine Hydrochloride
Intervention Trials
Schizophrenia 90
Parkinson's Disease 64
Parkinson Disease 50
Schizoaffective Disorder 27
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Dopamine Hydrochloride
Intervention Trials
Parkinson Disease 135
Schizophrenia 95
Disease 67
Cocaine-Related Disorders 50
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dopamine Hydrochloride

Trials by Country

Trials by Country for Dopamine Hydrochloride
Location Trials
United States 779
Canada 66
Germany 55
France 47
United Kingdom 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Dopamine Hydrochloride
Location Trials
New York 69
California 63
Maryland 59
Massachusetts 46
Connecticut 45
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dopamine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Dopamine Hydrochloride
Clinical Trial Phase Trials
Phase 4 154
Phase 3 105
Phase 2/Phase 3 28
[disabled in preview] 318
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Dopamine Hydrochloride
Clinical Trial Phase Trials
Completed 406
Recruiting 134
Unknown status 59
[disabled in preview] 127
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dopamine Hydrochloride

Sponsor Name

Sponsor Name for Dopamine Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 57
National Institute of Mental Health (NIMH) 34
Yale University 25
[disabled in preview] 57
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Dopamine Hydrochloride
Sponsor Trials
Other 915
Industry 180
NIH 154
[disabled in preview] 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Queensland Health
Fuji
Cerilliant
Johnson and Johnson
Moodys
Daiichi Sankyo
Citi
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.